Document is current
Any future updates will be listed below
-
Authors
Arnold, Matthias https://orcid.org/0000-0002-4666-0923
Nho, Kwangsik
Kueider-Paisley, Alexandra
Massaro, Tyler
Huynh, Kevin
Brauner, Barbara
MahmoudianDehkordi, Siamak
Louie, Gregory https://orcid.org/0000-0002-3267-7070
Moseley, M. Arthur
Thompson, J. Will
John-Williams, Lisa St
Tenenbaum, Jessica D. https://orcid.org/0000-0003-3532-565X
Blach, Colette
Chang, Rui
Brinton, Roberta D.
Baillie, Rebecca https://orcid.org/0000-0003-3966-6320
Han, Xianlin https://orcid.org/0000-0002-8615-2413
Trojanowski, John Q. https://orcid.org/0000-0002-9239-8794
Shaw, Leslie M.
Martins, Ralph
Weiner, Michael W.
Trushina, Eugenia
Toledo, Jon B.
Meikle, Peter J. https://orcid.org/0000-0002-2593-4665
Bennett, David A.
Krumsiek, Jan
Doraiswamy, P. Murali
Saykin, Andrew J. https://orcid.org/0000-0002-1376-8532
Kaddurah-Daouk, Rima https://orcid.org/0000-0003-1858-5732
Kastenmüller, Gabi https://orcid.org/0000-0002-2368-7322
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (RF1 AG058942, R01 AG057452, R03 AG054936, R01 LM012535, RF1 AG061872, P30AG10161, R01AG15819, U01AG46152, U01AG61356, R01 AG046171, RF1 AG051550, 3U01 AG024904-09S4, RF1 AG058942, RF1 AG058942, R01 AG057452)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Qatar National Research Fund (NPRP8-061-3-011, NPRP8-061-3-011)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
- License Information
-
More Information
Article History
Received: 22 May 2019
Accepted: 4 February 2020
First Online: 2 March 2020
Competing interests
: P.M.D. has received research grants (through Duke University) from Avid/Lilly, Neuronetrix, Avanir, Salix, Alzheimer’s Drug Discovery Foundation, DOD and NIH. P.M.D. has received speaking or advisory fees from Anthrotronix, Neuroptix, Genomind, Clearview, Verily, RBC, Brain Canada, and CEOs Against Alzheimer’s. P.M.D. owns shares in Muses Labs, Anthrotronix, Evidation Health, Turtle Shell Technologies, and Advera Health whose products are not discussed here. P.M.D. served on the board of Baycrest and serves on the board of Apollo Hospitals. P.M.D. is a co-inventor (through Duke) on patents relating to dementia biomarkers, metabolomics, and therapies, which are unlicensed. R.K.D. is inventor on key patents in the field of metabolomics, including applications for Alzheimer disease. M.A., J.B.T., G.K., M.A.M., J.W.T., R.B., X.H., L.S.J.W., A.J.S., K.N. are co-inventors on patent WO2018049268 in this field. J.B.T. further reports investigator-initiated research support from Eli Lilly unrelated to the work reported here. J.Q.T. may accrue revenue in the future on patents submitted by the University of Pennsylvania wherein he is a co-inventor and he received revenue from the sale of Avid to Eli Lilly as a co-inventor on imaging-related patents submitted by the University of Pennsylvania. L.M.S. is a consultant for Eli Lilly, Novartis, and Roche; he provides QC oversight for the Roche Elecsys immunoassay as part of responsibilities for the ADNI3 study. A.J.S. reports investigator-initiated research support from Eli Lilly unrelated to the work reported here. He has received consulting fees and travel expenses from Eli Lilly and Siemens Healthcare and is a consultant to Arkley BioTek. He also receives support from Springer publishing as an editor-in-chief of Brain Imaging and Behavior. M.W.W. reports stock/stock options from Elan, Synarc, travel expenses from Novartis, Tohoku University, Fundacio Ace, Travel eDreams, MCI Group, NSAS, Danone Trading, ANT Congress, NeuroVigil, CHRU-Hopital Roger Salengro, Siemens, AstraZeneca, Geneva University Hospitals, Lilly, University of California, San Diego–ADNI, Paris University, Institut Catala de Neurociencies Aplicades, University of New Mexico School of Medicine, Ipsen, Clinical Trials on Alzheimer’s Disease, Pfizer, AD PD meeting. All other authors declare no competing interests.
